Table 3 Evolution in memory outcomes according to plasma MCP-1 status
From: Plasma MCP-1 and changes on cognitive function in community-dwelling older adults
| Â | Low plasma MCP-1a | High plasma MCP-1 | Between-group differenceb | P value |
|---|---|---|---|---|
Within-group evolution Estimated mean (95% CI)c | Within-group evolution Estimated mean (95% CI) | Estimated difference (95%CI) | ||
FCSRT free recall,n= 1079 | ||||
 12 months | −1.28 (−1.66, −0.91) | −1.93 (−3.00, −0.85) | −0.65 (−1.73, 0.44) | 0.243 |
 24 months | −0.70 (−1.11, 0.30) | −1.56 (−2.69, −0.44) | −0.86 (−2.01, 0.29) | 0.142 |
 36 months | −1.56 (−2.03, −1.10) | −2.82 (−4.03, −1.60) | −1.25(−2.51, 0.01) | 0.051 |
 48 months | −1.82 (−2.33, −1.32) | −3.24 (−4.52, −1.96) | −1.42 (−2.76, −0.06) | 0.039 |
FCSRT total recall,n= 1079 | ||||
 12 months | −0.76 (−0.98, −0.55) | −1.63 (−2.22, −1.05) | −0.87 (−1.46, −0.27) | 0.004 |
 24 months | −0.40 (−0.64, −0.16) | −1.07 (−1.71, −0.44) | −0.68 (−1.33, −0.02) | 0.042 |
 36 months | −1.16 (−1.45,−0.88) | −1.81 (−2.52, −1.11) | −0.65 (−1.40, −0.10) | 0.089 |
 48 months | −1.09 (−1.42, −0.77) | −1.59 (−2.37, −0.82) | −0.50 (−1.33, 0.33) | 0.240 |
FCSRT free delayed recall,n= 1079 | ||||
 12 months | −0.13 (−0.30, 0.04) | −0.60 (−0.96, −0.24) | −0.47 (−0.84, −0.10) | 0.090 |
 24 months | −0.17 (−0.35, 0.01) | −0.52 (−0.90, −0.15) | −0.35 (−0.74, 0.04) | 0.206 |
 36 months | −0.32 (−0.52, −0.11) | −0.82 (−1.23, −0.41) | −0.50 (−0.04, −0.07) | 0.045 |
 48 months | −0.54 (−0.75, −0.32) | −1.06 (1−49, −0.63) | −0.52 (−0.98, −0.06) | 0.024 |
FCSRT total delayed recall,n= 1079 | ||||
 12 months | −0.10 (−0.18, 0.02) | −0.34 (−0.53, −0.15) | −0.24 (−0.44, −0.05) | 0.014 |
 24 months | −0.10 (−0.19, −0.02) | −0.38 (−0.59, −0.17) | −0.28 (−0.50, −0.05) | 0.015 |
 36 months | −0.32 (−0.42, −0.21) | −0.46 (−0.71, −0.22) | −0.15 (−0.41, 0.12) | 0.284 |
 48 months | −0.35 (−0.47, −0.23) | −0.77 (−1.05, −0.49) | −0.42 (−0.72, −0.12) | 0.007 |